Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,699.38
(
1.01%
)
US TECH 100
23,895.60
(
-0.50%
)
Dow Jones
46,946.41
(
0.83%
)
Brent Oil
101.04
(
2.78%
)
Bitcoin
74,396.60
(
-0.60%
)
News Focus
News Focus
Post# of 257250
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122790
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 111761

Tuesday, 02/08/2011 1:59:34 PM

Tuesday, February 08, 2011 1:59:34 PM

Post# of 257250
Teva provides 2011 sales and EPS* guidance:

http://finance.yahoo.com/news/Teva-Provides-2011-NonGAAP-bw-347244221.html?x=0&.v=1

It’s clear from Teva’s CC today that no contribution from Lovenox is in Teva’s 2011 guidance. (Nor, for that matter, has any contribution from Lovenox ever been in Teva’s prior guidance—see #msg-58308206.)

Please see #msg-56956538 for Teva’s sales and EPS guidance for 2015, which is unchanged.

*Non-GAAP.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now